Molecular benchmarks of a SARS-CoV-2 epidemic
The concentration of SARS-CoV-2 changes during an individual’s infection, and mutations accumulate as viruses are transmitted between people. Here, the authors use data from Iceland to demonstrate how this information can be exploited at the population-level to determine the phase of the epidemic.
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/09b4d305bbe74a81ada5dc0798d210f2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:09b4d305bbe74a81ada5dc0798d210f2 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:09b4d305bbe74a81ada5dc0798d210f22021-12-02T17:23:50ZMolecular benchmarks of a SARS-CoV-2 epidemic10.1038/s41467-021-23883-62041-1723https://doaj.org/article/09b4d305bbe74a81ada5dc0798d210f22021-06-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-23883-6https://doaj.org/toc/2041-1723The concentration of SARS-CoV-2 changes during an individual’s infection, and mutations accumulate as viruses are transmitted between people. Here, the authors use data from Iceland to demonstrate how this information can be exploited at the population-level to determine the phase of the epidemic.Hakon JonssonOlafur T. MagnussonPall MelstedJonas BerglundArna B. AgustsdottirBerglind EiríksdottirRun FridriksdottirElisabet Eir GarðarsdottirGudmundur GeorgssonOlafia S. GretarsdottirKjartan R. GuðmundssonThora Rosa GunnarsdottirHannes EggertssonArnaldur GylfasonHilma HolmBrynjar O. JenssonAslaug JonasdottirFrosti JonssonKamilla S. JosefsdottirMarianna ThordardottirKarl G. KristinssonÞórður KristjánssonDroplaug N. MagnusdottirLouise le RouxJona SaemundsdottirAsgeir SigurdssonGudrun SigmundsdottirGardar SveinbjornssonSolvi RognvaldssonOgmundur EirikssonMagnus Karl MagnussonKristin Eva SveinsdottirManey SveinsdottirEmil Aron ThorarensenBjarni ThorbjornssonArthur LöveGudmundur L. NorddahlIngileif JonsdottirPatrick SulemGisli MassonAlma MollerThorolfur GudnasonMar KristjanssonAgnar HelgasonDaniel F. GudbjartssonUnnur ThorsteinsdottirKari StefanssonNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-8 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Science Q |
| spellingShingle |
Science Q Hakon Jonsson Olafur T. Magnusson Pall Melsted Jonas Berglund Arna B. Agustsdottir Berglind Eiríksdottir Run Fridriksdottir Elisabet Eir Garðarsdottir Gudmundur Georgsson Olafia S. Gretarsdottir Kjartan R. Guðmundsson Thora Rosa Gunnarsdottir Hannes Eggertsson Arnaldur Gylfason Hilma Holm Brynjar O. Jensson Aslaug Jonasdottir Frosti Jonsson Kamilla S. Josefsdottir Marianna Thordardottir Karl G. Kristinsson Þórður Kristjánsson Droplaug N. Magnusdottir Louise le Roux Jona Saemundsdottir Asgeir Sigurdsson Gudrun Sigmundsdottir Gardar Sveinbjornsson Solvi Rognvaldsson Ogmundur Eiriksson Magnus Karl Magnusson Kristin Eva Sveinsdottir Maney Sveinsdottir Emil Aron Thorarensen Bjarni Thorbjornsson Arthur Löve Gudmundur L. Norddahl Ingileif Jonsdottir Patrick Sulem Gisli Masson Alma Moller Thorolfur Gudnason Mar Kristjansson Agnar Helgason Daniel F. Gudbjartsson Unnur Thorsteinsdottir Kari Stefansson Molecular benchmarks of a SARS-CoV-2 epidemic |
| description |
The concentration of SARS-CoV-2 changes during an individual’s infection, and mutations accumulate as viruses are transmitted between people. Here, the authors use data from Iceland to demonstrate how this information can be exploited at the population-level to determine the phase of the epidemic. |
| format |
article |
| author |
Hakon Jonsson Olafur T. Magnusson Pall Melsted Jonas Berglund Arna B. Agustsdottir Berglind Eiríksdottir Run Fridriksdottir Elisabet Eir Garðarsdottir Gudmundur Georgsson Olafia S. Gretarsdottir Kjartan R. Guðmundsson Thora Rosa Gunnarsdottir Hannes Eggertsson Arnaldur Gylfason Hilma Holm Brynjar O. Jensson Aslaug Jonasdottir Frosti Jonsson Kamilla S. Josefsdottir Marianna Thordardottir Karl G. Kristinsson Þórður Kristjánsson Droplaug N. Magnusdottir Louise le Roux Jona Saemundsdottir Asgeir Sigurdsson Gudrun Sigmundsdottir Gardar Sveinbjornsson Solvi Rognvaldsson Ogmundur Eiriksson Magnus Karl Magnusson Kristin Eva Sveinsdottir Maney Sveinsdottir Emil Aron Thorarensen Bjarni Thorbjornsson Arthur Löve Gudmundur L. Norddahl Ingileif Jonsdottir Patrick Sulem Gisli Masson Alma Moller Thorolfur Gudnason Mar Kristjansson Agnar Helgason Daniel F. Gudbjartsson Unnur Thorsteinsdottir Kari Stefansson |
| author_facet |
Hakon Jonsson Olafur T. Magnusson Pall Melsted Jonas Berglund Arna B. Agustsdottir Berglind Eiríksdottir Run Fridriksdottir Elisabet Eir Garðarsdottir Gudmundur Georgsson Olafia S. Gretarsdottir Kjartan R. Guðmundsson Thora Rosa Gunnarsdottir Hannes Eggertsson Arnaldur Gylfason Hilma Holm Brynjar O. Jensson Aslaug Jonasdottir Frosti Jonsson Kamilla S. Josefsdottir Marianna Thordardottir Karl G. Kristinsson Þórður Kristjánsson Droplaug N. Magnusdottir Louise le Roux Jona Saemundsdottir Asgeir Sigurdsson Gudrun Sigmundsdottir Gardar Sveinbjornsson Solvi Rognvaldsson Ogmundur Eiriksson Magnus Karl Magnusson Kristin Eva Sveinsdottir Maney Sveinsdottir Emil Aron Thorarensen Bjarni Thorbjornsson Arthur Löve Gudmundur L. Norddahl Ingileif Jonsdottir Patrick Sulem Gisli Masson Alma Moller Thorolfur Gudnason Mar Kristjansson Agnar Helgason Daniel F. Gudbjartsson Unnur Thorsteinsdottir Kari Stefansson |
| author_sort |
Hakon Jonsson |
| title |
Molecular benchmarks of a SARS-CoV-2 epidemic |
| title_short |
Molecular benchmarks of a SARS-CoV-2 epidemic |
| title_full |
Molecular benchmarks of a SARS-CoV-2 epidemic |
| title_fullStr |
Molecular benchmarks of a SARS-CoV-2 epidemic |
| title_full_unstemmed |
Molecular benchmarks of a SARS-CoV-2 epidemic |
| title_sort |
molecular benchmarks of a sars-cov-2 epidemic |
| publisher |
Nature Portfolio |
| publishDate |
2021 |
| url |
https://doaj.org/article/09b4d305bbe74a81ada5dc0798d210f2 |
| work_keys_str_mv |
AT hakonjonsson molecularbenchmarksofasarscov2epidemic AT olafurtmagnusson molecularbenchmarksofasarscov2epidemic AT pallmelsted molecularbenchmarksofasarscov2epidemic AT jonasberglund molecularbenchmarksofasarscov2epidemic AT arnabagustsdottir molecularbenchmarksofasarscov2epidemic AT berglindeiriksdottir molecularbenchmarksofasarscov2epidemic AT runfridriksdottir molecularbenchmarksofasarscov2epidemic AT elisabeteirgarðarsdottir molecularbenchmarksofasarscov2epidemic AT gudmundurgeorgsson molecularbenchmarksofasarscov2epidemic AT olafiasgretarsdottir molecularbenchmarksofasarscov2epidemic AT kjartanrguðmundsson molecularbenchmarksofasarscov2epidemic AT thorarosagunnarsdottir molecularbenchmarksofasarscov2epidemic AT hanneseggertsson molecularbenchmarksofasarscov2epidemic AT arnaldurgylfason molecularbenchmarksofasarscov2epidemic AT hilmaholm molecularbenchmarksofasarscov2epidemic AT brynjarojensson molecularbenchmarksofasarscov2epidemic AT aslaugjonasdottir molecularbenchmarksofasarscov2epidemic AT frostijonsson molecularbenchmarksofasarscov2epidemic AT kamillasjosefsdottir molecularbenchmarksofasarscov2epidemic AT mariannathordardottir molecularbenchmarksofasarscov2epidemic AT karlgkristinsson molecularbenchmarksofasarscov2epidemic AT þorðurkristjansson molecularbenchmarksofasarscov2epidemic AT droplaugnmagnusdottir molecularbenchmarksofasarscov2epidemic AT louiseleroux molecularbenchmarksofasarscov2epidemic AT jonasaemundsdottir molecularbenchmarksofasarscov2epidemic AT asgeirsigurdsson molecularbenchmarksofasarscov2epidemic AT gudrunsigmundsdottir molecularbenchmarksofasarscov2epidemic AT gardarsveinbjornsson molecularbenchmarksofasarscov2epidemic AT solvirognvaldsson molecularbenchmarksofasarscov2epidemic AT ogmundureiriksson molecularbenchmarksofasarscov2epidemic AT magnuskarlmagnusson molecularbenchmarksofasarscov2epidemic AT kristinevasveinsdottir molecularbenchmarksofasarscov2epidemic AT maneysveinsdottir molecularbenchmarksofasarscov2epidemic AT emilaronthorarensen molecularbenchmarksofasarscov2epidemic AT bjarnithorbjornsson molecularbenchmarksofasarscov2epidemic AT arthurlove molecularbenchmarksofasarscov2epidemic AT gudmundurlnorddahl molecularbenchmarksofasarscov2epidemic AT ingileifjonsdottir molecularbenchmarksofasarscov2epidemic AT patricksulem molecularbenchmarksofasarscov2epidemic AT gislimasson molecularbenchmarksofasarscov2epidemic AT almamoller molecularbenchmarksofasarscov2epidemic AT thorolfurgudnason molecularbenchmarksofasarscov2epidemic AT markristjansson molecularbenchmarksofasarscov2epidemic AT agnarhelgason molecularbenchmarksofasarscov2epidemic AT danielfgudbjartsson molecularbenchmarksofasarscov2epidemic AT unnurthorsteinsdottir molecularbenchmarksofasarscov2epidemic AT karistefansson molecularbenchmarksofasarscov2epidemic |
| _version_ |
1718380949795766272 |